ES

Elizabeth Stoner

Arovella Therapeutics Limited | Non-Executive Director
Dr Stoner has over 30 years of experience in the life-science sector. She is currently an executive partner at MPM Capital, a leading US healthcare investment firm. In her role, Dr Stoner serves as a clinical advisor to several of MPM Capital's portfolio companies, including Antiva, and Rhythm Pharmaceuticals.

Company and Role

Company
Title
Tenure
Since
ALA
ALA
Arovella Therapeutics Limited
  • Non-Executive Director
3yrs, 2mthNov 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ALA
ALA
Arovella Therapeutics Limited
26/11/24763,157N/A8,172,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ALA
ALA
Arovella Therapeutics Limited
26/11/24
Issued
354,000$0.185$65,490Director remuneration
ALA
ALA
Arovella Therapeutics Limited
04/12/23
Issued
618,000$0.088$54,384Director remuneration
ALA
ALA
Arovella Therapeutics Limited
05/05/23
Issued
500,000$0.020$10,000Placement
ALA
ALA
Arovella Therapeutics Limited
15/12/22
Issued
4,800,000$0.025$120,000Director remuneration
ALA
ALA
Arovella Therapeutics Limited
16/03/22
Issued
263,157$0.038$9,999Placement